Physician profile
Michelle Steinmann
NPI 1790435394
$710.32
in general payments reported to CMS, 2019-2025
10 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.13 · 2024: $449 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $191.33 | 2024-2025 | Watchman Flx |
| Abbvie INC. | $159.57 | 2024-2025 | |
| Medtronic, INC. | $141.49 | 2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Pfizer INC. | $76.45 | 2023-2025 | |
| Spr Therapeutics, INC | $36.63 | 2024-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $24.14 | 2024 | Prospera |
| Collegium Pharmaceutical, INC. | $22.53 | 2025 | Belbuca |
| Painteq LLC | $20.46 | 2024 | Painteq |
| Scilex Pharmaceuticals INC. | $19.42 | 2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.30 | 2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Steinmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.